Semaglutide 10mg
Intermediate Dose — Where Real Results Begin
The intermediate format for researchers who have completed the escalation from 5mg and are now in the therapeutic range where meaningful, sustained fat loss occurs.
Starting From
$99.99
Sold By
Apollo Peptide Sciences
Suggested Protocol
Intended for researchers who have completed dose escalation on the 5mg vial and are dosing at 1–2mg weekly. Reconstitute with 1–2ml bacteriostatic water for a working concentration of 5–10mg/ml. SubQ injection once weekly. Continue escalation to 2.4mg maintenance as tolerated.
14.9%
Body Wt. Loss
5–10 wks
Duration
10 mg vial
Format
Moving Into the Zone Where Semaglutide Actually Delivers What the Trials Showed
The 10mg semaglutide vial represents the pivot point in any serious research protocol — the transition from dose escalation into the therapeutic range where clinically significant fat loss is achieved and sustained. Researchers who have completed the initial 5mg escalation protocol have already adapted to the compound's GI profile; the 10mg vial provides the volume needed to operate confidently at doses of 1–2mg weekly without the pressure of a smaller vial running short mid-protocol.
At therapeutic doses of 1–2mg weekly, semaglutide's GLP-1 receptor engagement reaches the level demonstrated in the STEP trial program to drive meaningful, clinically significant weight reduction. The 10mg vial provides approximately 5–10 weeks of research supply at 1–2mg weekly dosing — the sustained duration needed for the compound's cumulative appetite-modulating effects to produce measurable body composition changes.
The cost advantage over purchasing two 5mg vials for the same total volume is meaningful for longer research programs. A single 10mg vial is not only more economical per milligram but also more practical: fewer reconstitution events mean less handling, fewer opportunities for contamination, and a cleaner protocol management workflow. Paired with bacteriostatic water, it reconstitutes cleanly to any desired concentration.
For those running the standard dose escalation from 0.25mg to 2.4mg, the 10mg vial serves as the ideal bridge between the entry-level 5mg and the long-term maintenance 15mg format — covering the critical months where the body's response to semaglutide is most actively established.
The Therapeutic Range
What Changes at 1–2mg Weekly vs. the Starter Escalation Doses
At 0.25–0.5mg weekly during the escalation phase, you're adapting your GI tract — not yet in the dose range where semaglutide's full appetite-suppressing and metabolic effects are expressed. The shift happens in the 1–2mg weekly range: hypothalamic GLP-1 receptor engagement reaches the level where hunger signals are meaningfully suppressed, gastric emptying is consistently slowed, and the metabolic improvements in insulin sensitivity become measurable. The 10mg vial is the right format because it covers 5–10 weeks at this dose without the pressure of a smaller vial running short before you've completed the transition.
From 5mg to 10mg
When You're Ready to Step Up — and How to Know
The 5mg vial is the right starting format: it covers the full escalation from 0.25mg to 1mg weekly with supply to spare, and it keeps the financial commitment appropriate for a phase where you're still establishing tolerability. Once you've completed that escalation and confirmed that semaglutide works for you — appetite is suppressed, GI side effects have settled — the 10mg vial is the natural next step. It's not more compound per injection; it's the same doses for longer, covering the weeks of consistent therapeutic-range dosing where measurable fat loss actually accumulates.
Fewer Reconstitutions
Why Single-Vial Supply Continuity Matters More Than It Sounds
Every reconstitution is a handling event: you're introducing a needle, mixing compounds, and creating a window for contamination or measurement error. Two 5mg vials require two reconstitutions to cover the same total compound volume as one 10mg vial. For researchers running multi-week protocols, fewer reconstitution events means fewer opportunities for error and lower cumulative contamination risk. The 10mg vial also simplifies tracking — one vial, one reconstitution date, one refrigerated storage entry — for cleaner protocol management across a multi-month research timeline.
Key Benefits
Covers the full therapeutic dose range (1–2mg weekly) for 5–10 weeks of research
Lower cost per milligram than two separate 5mg vials
Fewer reconstitution events reduce handling and contamination risk
Ideal transition format from entry-level 5mg escalation protocols
Supports dosing flexibility — concentrate adjustment for any target dose
The dose range where STEP trial fat loss outcomes were meaningfully achieved
Efficient single-vial management for mid-protocol research continuity
Bridges the gap between 5mg starter and 15mg long-term maintenance vials
Full Protocol
Intended for researchers who have completed dose escalation on the 5mg vial and are dosing at 1–2mg weekly. Reconstitute with 1–2ml bacteriostatic water for a working concentration of 5–10mg/ml. SubQ injection once weekly. Continue escalation to 2.4mg maintenance as tolerated.
Best Stacked With
More in Weight Management
View All
Semaglutide
The compound behind Ozempic/Wegovy. GLP-1 receptor agonist producing significant appetite suppression, fat loss, and metabolic improvement with once-weekly dosing.
